T2	Participants 222 287	patients with congestive heart failure and ventricular arrhythmia
T1	Participants 0 56	Veterans Affairs congestive heart failure antiarrhythmic
T3	Participants 356 498	Eligible patients include those with ischemic and nonischemic congestive heart failure and with > or = 10 ventricular premature beats per hour
T4	Participants 500 752	All patients must have shortness of breath with minimal exertion or paroxysmal nocturnal dyspnea, a left ventricular internal dimension (LVIDd) by echocardiogram of > or = 55 mm or a cardiothoracic ratio of > 0.5 and an ejection fraction of < or = 40%.
T5	Participants 753 831	All patients will receive vasodilator therapy, unless they find it intolerable
T6	Participants 833 925	Patients will be entered into the study for 2.5 years and followed for an additional 2 years
T7	Participants 1101 1174	674 patients will be entered into the study from 25 participating centers
